COVID-19 Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B8AT
|
|||
| Drug Name |
PB28
|
|||
| Synonyms |
Pigment Blue 28
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H38N2O
|
|||
| Canonical SMILES |
COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
|
|||
| InChI |
1S/C24H38N2O/c1-27-24-14-6-12-22-20(8-5-13-23(22)24)9-7-15-25-16-18-26(19-17-25)21-10-3-2-4-11-21/h6,12,14,20-21H,2-5,7-11,13,15-19H2,1H3
|
|||
| InChIKey |
PHRCDWVPTULQMT-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 172906-90-0
|
|||
| PubChem Compound ID | ||||
| Target | Top | |||
|---|---|---|---|---|
| Target(s) | HUMAN opioid receptor sigma 1 (OPRS1) | Target Info | Modulator | [2] |
| PB28 binds to Sigma receptors, which participates in ER stress response and thus leads to inhibition of its interaction with SARS-CoV-2 Nsp6 protein. | ||||
| HUMAN sigma intracellular receptor 2 (TMEM97) | Target Info | Modulator | [2] | |
| PB28 binds to Sigma receptors, which participates in ER stress response and thus leads to inhibition of its interaction with SARS-CoV-2 Nsp6 protein. | ||||
| References | Top | |||
|---|---|---|---|---|
| 1 | Cyclohexylpiperazine Derivative PB28, a sigma2 Agonist and sigma1 Antagonist Receptor, Inhibits Cell Growth, Modulates P-glycoprotein, and Synergizes With Anthracyclines in Breast Cancer. Mol Cancer Ther. 2006 Jul;5(7):1807-16. doi: 10.1158/1535-7163.MCT-05-0402. | |||
| 2 | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.